Terumo Corporation (TRUMF) 19.8500 $TRUMF
Neurovascular Interventions - EU Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nd4wcl/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - EU Analysis and Market Forecasts" report to their offering. The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices. The neurovascular interventions market in the 5EU is a vast and dynamic market that consists of innovative and emerging technologies. Neurointerventional devices can be used to treat a variety of cerebrovascular indications such as intracranial aneurysms, AVMs, and dural AVFs, atherosclerotic disease, and stroke. In this report, the neurointerventional market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. Scope - An overview of Neurovascular, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the EU Neurovascular market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Neurovascular. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Neurovascular sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/nd4wcl/medipoint
MediPoint Report: Neurovascular Interventions - APAC Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cn25dz/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - APAC Analysis and Market Forecasts" report to their offering. The APAC neurovascular interventions market is a vast and dynamic market that consists of innovative and emerging technologies. Neurointerventional devices can be used to treat a variety of cerebrovascular indications such as intracranial aneurysms, AVMs, and dural AVFs, atherosclerotic disease, and stroke. In this report, the neurointerventional market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 Market Outlooks 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/cn25dz/medipoint
MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zzfs96/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts" report to their offering. The neurovascular interventions market will be driven by the rising prevalence of disease, the growing aging population, and the potential cost savings. The adoption of innovative technologies such as flow diverters and stent retrievers in Brazil will depend on the cost of, and availability of reimbursement for these devices. Flow diverters and stent retrievers are currently not reimbursed by the Brazilian public healthcare system and are associated with high costs. Scope - An overview of Neurovascular Interventions, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized South America Neurovascular Interventions market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Neurovascular Interventions. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Neurovascular Interventions sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/zzfs96/medipoint
MediPoint: US Neurovascular Interventions Analysis and Market Forecasts 2014-2020
M2 - Wed May 07, 8:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b4sqvw/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - US Analysis and Market Forecasts" report to their offering. The neurovascular interventions market in the US to reach $702m by 2020, increasing slowly throughout the forecast period. The neurovascular interventions market will be driven by: the rising prevalence of cerebrovascular disease; the cost savings incurred by government agencies, such as Medicare, and private health insurance companies; and the adoption of innovative technologies such as flow diverters and stent retrievers. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 US Market Outlook 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/b4sqvw/medipoint
Global Infusion Pumps Market 2013-2019 with CareFusion, Hospira, Baxter International, Fresenius Kabi, & Terumo Dominating
M2 - Tue Apr 22, 5:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kbssn4/infusion_pumps) has announced the addition of the "Infusion Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Infusion pumps are used to deliver therapeutic drugs and fluids such as plasma, dextrose and saline solutions, into a patient's body at a precisely controlled rate. These devices are efficiently used for infusion through several routes of administration such as intravenous, epidural, arterial, subcutaneous, peritoneal, enteral and intrathecal. The global infusion pumps market has witnessed significant growth in the past due to factors such as worldwide increase in number of patients with chronic pain, diabetes and cancer. This report provides an in-depth, comprehensive analysis of the global infusion pumps market from the three perspectives namely types of products, different applications and the major geographies. According to the type of products, the market is further segmented into five sub-categories namely large volume, disposable, syringe, ambulatory, and implantable infusion pumps. The report analyzes the market for various applications namely; analgesia, chemotherapy, diabetes, clinical nutrition and others. In addition to this, the global infusion pumps market has also been classified by the pumping channel type, into single channel and multiple channel infusion pumps. A detailed market analysis and forecast for these segments has been provided in this study, in terms of market revenue (USD million) for the period 2011 to 2019. The report also provides the compounded annual growth rate (CAGR %) for each product type and for geographic region for the forecast period 2013 to 2019, while market size estimations have been made considering 2012 as the base year and 2011 as a historical year. The market overview section of the report demonstrates the market dynamics and trends such as the drivers, restraints and opportunities which influence the current nature and also affect the future status of this field. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global infusion pumps market. Scope Products - Large Volume Infusion Pumps - Disposable Infusion Pumps - Syringe Infusion Pumps - Ambulatory Infusion Pumps - Implantable Infusion Pumps Pumping Channel - Single Channel Infusion Pumps - Multiple Channel Infusion Pumps Application Areas - Analgesia - Chemotherapy - Diabetes - Clinical Nutrition Key Topics Covered: - Introduction - Executive Summary - Global Infusion Pumps Market Overview - Global Infusion Pumps Market, by Product Type, 2011 - 2019 (USD Million) - Global Infusion Pumps Market, by Channel Type, 2011 - 2019 (USD Million) - Global Infusion Pumps Market, by Application, 2011 - 2019 (USD Million) - Global Infusion Pumps Market, by Geography, 2011 - 2019 (USD Million) - Competitive Landscape - Recommendations - Company Profiles - Animas Corporation - B. Braun Melsungen AG - Baxter International Inc. - CareFusion Corporation - Fresenius Kabi AG - Hospira, Inc. - KD Scientific, Inc. - Medtronic, Inc. - Smiths Medical - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/kb...sion_pumps
Global Central Venous Access Devices Market Forecasts & Opportunities Report, 2018
M2 - Tue Apr 22, 2:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xdl79x/global_central) has announced the addition of the "Global Central Venous Access Devices Market Forecasts & Opportunities Report, 2018" report to their offering. One of the main drivers in this market is the increasing aging population that has led to an increase in demand for central venous access devices for delivering drugs, nutritional support, or aspiration of blood for sampling. Following the change of reimbursement policies (offered under Medicare and Medicaid) in the recent past, there has been an increase in the use of antimicrobial catheters. According to the changes, reimbursement would no longer be provided for treatment of vascular access-related infections acquired during a patient's hospitalization. The antimicrobial CVCs are inserted directly into the bloodstream through the large internal jugular, subclavian, and femoral veins, making them highly susceptible to infection. The complete CVC kits include maximum barrier drapes, manufactured catheter securement devices, and the antimicrobial agent (chlorhexidine) that is highly adopted by surgeons. The demand for dialysis catheters with intraluminal antimicrobial properties has also increased over the years. In addition, antimicrobial PICCs are extensively used to deliver chemotherapy and antibiotics as well as for drawing blood from immunocompromised patients. Further, the report states that one of the major challenges faced by the market is the high risk of vein thrombosis that can lead to a pulmonary embolism and may prove to be fatal. Key vendors dominating this space are: - AngioDynamics Inc. - B. Braun Melsungen AG - Becton, Dickinson and Co. - Cook Medical Inc - C.R Bard Inc - Teleflex Inc. Other vendors mentioned in the report are: - Boston Scientific Corp - Covidien Plc - Edwards Lifesciences Corp. - Medical Components Inc - Smiths Medical - Terumo Corp. - Vygon Corp. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/xd...al_central
Global Drug-eluting Stent Market 2014-2018 with Abbott Laboratories, Boston Scientific, Medtronic & Terumo Dominating
M2 - Thu Apr 17, 5:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c6b9zf/global) has announced the addition of the "Global Drug-eluting Stent Market 2014-2018 with Abbott Laboratories, Boston Scientific, Medtronic & Terumo Dominating" report to their offering. One of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD. Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries. Further, the report states that the biggest challenge the market is facing is the decline in the ASP of DESs. There has been a steady decline in the prices of DESs worldwide because of the increased competition and the high rate of adoption. The reduction in the ASP has a negative impact on the overall market revenue. Key vendors dominating this space are: - Abbott Laboratories - Boston Scientific Corp - Medtronic Inc. - Terumo Corp. Other vendors mentioned in the report are: - B. Braun Melsungen AG - Biosensors International Ltd - BIOTRONIK SE & Co. KG - Cook Medical Inc. - Lepu Medical Technology Co. Ltd - MicroPort Scientific Corp. - Sorin Group USA Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Types of Drugs - Geographical Segmentation - Key Leading Countries - Rate of Incidence and Prevalence - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/c6b9zf/global
Global Peripheral I.V. Catheter Market 2014-2018 with Braun, CR Bard, Smiths Medical, Teleflex, Terumo & Becton Dickension Dominating
M2 - Wed Apr 16, 5:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zzpzkc/global_peripheral) has announced the addition of the "Global Peripheral I.V. Catheter Market 2014-2018 with Braun, CR Bard, Smiths Medical, Teleflex, Terumo & Becton Dickension Dominating" report to their offering. The Global Peripheral I.V. Catheter market to grow at a CAGR of 8.08 percent over the period 2013-2018. The Global Peripheral I.V. Catheter market is driven by several factors, a major one being the increasing aging population. The elderly require peripheral I.V. catheters to deliver drugs and nutrition, and for taking blood samples. Also, WHO statistics state that nearly 2 billion people will be aged 60 years and above by 2050, which will also enhance the market's growth in the future. One of the emerging trends in the market is the adoption of power-injectable closed catheters for the injection of contrast media during CT imaging. CT imaging requires a contrast media to be used for enhanced visualization during diagnostic procedures. However, the catheter must be strong enough to withstand pressures that can be more than 300 psi. Hence, power-injectable closed catheters are used for CT imaging as they are made of polyurethane material, which is much stronger than silicone and can withstand high pressures with a minimal decrease in flexibility. For example, BD Nexiva closed I.V. catheter of BD helps inject contrast media for contrast-enhanced CT scans. Further, the report states that the high cost of integrated/closed catheters is proving to be a hindrance to the adoption of these catheters, particularly in developing countries. Closed catheters are offered at an average selling price of more than US$4, which makes their adoption quite difficult in developing countries. Key Vendors - B. Braun Melsungen AG - Becton, Dickenson and Co. - C.R. Bard Inc. - Smiths Medical - Tangent Medical Technologies - Teleflex Inc. - Terumo Corp. Other Prominent Vendors - Argon Medical Devices Inc. - Medical Components Inc. - Vascular Pathways Inc. - VIGMED AB - Vygon SA Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Global Vascular Access Catheter Market Segmentation - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/zz...peripheral
Global Infusion Pumps & Accessories (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump) Market 2014-2018
M2 - Fri Apr 11, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n6xwqb/infusion_pumps) has announced the addition of the "Infusion Pumps & Accessories Market by Product, Application & by End-user - Global Forecasts to 2018" report to their offering. The infusion pumps market is expected to grow at a moderate CAGR from 2013 to 2018 due to factors such as increasing chronic diseases, rising applications of infusion products in home care, and favorable reimbursement coverage for the use of infusion products. Despite of these growth factors, the increasing errors with use of infusion pumps and rising pressures to meet with stringent regulatory requirements may hamper the growth of this market to a certain extent. The global market is segmented on the basis of product types, applications, end users, and geographies. Based on the type of product, the market is further segmented into devices (pumps) and accessories/disposables. The accessories/disposables are further segmented into dedicated disposables and non-dedicated disposables. Depending on the application area, the market is classified into diabetes, chemotherapy/oncology, gastroenterology, hematology, analgesia/pain management, pediatrics/neonatology, and others. Based on end users, the market is categorized into hospitals, home care, and others. The overall market is further divided into four major geographies, namely North America, Europe, Asia-Pacific, and the Rest of the World (RoW). These regions are further analyzed at the country level. In 2013, the volumetric infusion pumps segment commanded the largest share of the global market and is expected to grow with moderate CAGR in next five years. The increasing applications and acceptance of insulin infusion pumps, patient controlled analgesia pumps, and implantable infusion pumps is expected to push the growth of these segments at a strong CAGR during the forecast period of 2013 to 2018. North America dominated the infusion pumps market in 2013, accounting for a share of around 40% to 45%. However, the developed geographies like North America and Europe are likely to grow at lower CAGRs than the Asia-Pacific and RoW markets. The growing economical condition, increasing healthcare expenditures, and rising adoption of newer technologies in the Asia-Pacific region will drive the market in this region. Scope Product - Volumetric - Syringe - Enteral - Insulin - Implantable - PCA Pump Application - Diabetes - Chemotherapy - Nutrition - Pain Management Key Topics Covered: - Introduction - Executive Summary - Premium Insight - Market Dynamics - Infusion Pumps & Accessories Market, By Product - Infusion Pumps And Accessories Market, By Application - Infusion Pumps And Accessories Market, By End User - Geographic Analysis - Competitive Landscape - Company Profiles - B. Braun Melsungen Ag - Baxter International Inc. - Carefusion Corporation - Fresenius Se & Co. Kgaa - ospira, Inc. - Johnson & Johnson - Medtronic, Inc. - Moog Inc. - Smiths Medical - Terumo Corporation Visit http://www.researchandmarkets.com/research/n6...sion_pumps
EnteroMedics Inc. Appoints Mark Bullivant as Vice President of Marketing
Marketwire - Wed Apr 09, 6:01AM CDT
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, is pleased to announced that Mark Bullivant has joined the organization as Vice President of Marketing. He will report to Greg S. Lea, Senior Vice President, Chief Financial Officer and Chief Operating Officer. Most recently, Mr. Bullivant was Vice President of Global Marketing and International Sales at Terumo Heart Inc., a subsidiary of Terumo Corporation where he was responsible for developing strategic sales and marketing plans with focus on expanding the business in US and International markets. Mark brings 20 years of product management experience in both the medical and surgical fields.
Neurovascular Interventions - Global Analysis and Market Forecasts 2014
M2 - Tue Apr 08, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/95ztzv/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts" report to their offering. Sales of Neurointerventional Devices by Region In this report, the neurovascular interventions market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. In 2013 in the 10MM, the neurovascular interventions market was approximately $1.37bn. We estimate the 2014 sales of neurointerventional devices for cerebrovascular applications to be $1.40bn across the 10 countries covered in this report, which are the US, France, Germany, Italy, Spain, the UK, Japan, China, India, and Brazil. Embolization, revascularization, and mechanical thrombectomy devices can be used for a wide range of cerebrovascular indications including intracranial aneurysms and arteriovenous malformations (AVMs), dural arteriovenous fistulas (DAVFs), atherosclerotic disease, and stroke. Endovascular therapy for neurovascular applications is rapidly expanding and provides effective results. The key drivers for this market during the forecast period are: - The rising prevalence of cerebrovascular disease and its associated risk factors in the major markets covered in this report. - The need for effective therapies that reduce the risk of hemorrhagic and stroke complications, and ensure long-term, reliable outcomes. - The improved outcomes with endovascular coiling for intracranial aneurysm treatment compared with surgical therapy. - The increased use of remodeling techniques such as stent-assisted and balloon-assisted coiling, and the adoption of flow diverters for the treatment of challenging/complex aneurysms (wide-neck, large, and giant aneurysms). - Improved recanalization rates with mechanical thrombectomy systems, where the need for chemical thrombolysis is eliminated, thereby reducing the risk of intracranial hemorrhage. - The cost savings for healthcare payers resulting from the reduced need for repeat procedures. - The increase in patients' disposable income and government insurance coverage in the emerging markets, such as China and India. - The approval and launch of the next-generation of innovative embolization, revascularization, and mechanical thrombectomy devices in the US and Japan. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 Market Outlooks 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/95ztzv/medipoint
Arterial Remodeling Technologies ('ART'
signs structured buyout agreement with Terumo, validating ART's next-gen bioresorbable scaffold
Business Wire - Thu Mar 27, 8:44AM CDT
Privately held Arterial Remodeling Technologies ('ART' announced today that it has signed a structured buyout agreement with Terumo Corporation. Under the agreement, ART and Terumo Corporation will collaborate in the development of a drug eluting bioresorbable scaffold or stent, intended for use in the treatment of coronary artery disease. ART Security Holders will retain full ownership of the ART bioresorbable scaffold technology for all other indications. Terumo Corporation will make staged R&D investments in ART and ART has granted an exclusive option to Terumo Corporation to purchase ART at any time prior to the initiation of clinical trials.
Drug Device Combination Products Market Report 2013 - 2019: Forecasts & Trends for the $US100 Billion Market
M2 - Tue Mar 18, 11:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wmt3kk/drug_device) has announced the addition of the "Drug Device Combination Products Market Report 2013 - 2019: Forecasts & Trends for the $US100 Billion Market" report to their offering. The global drug device combination products market was valued at USD 66 billion in 2012 and is expected to grow at a CAGR of 7.9% from 2013 to 2019, to reach an estimated value of USD 115 billion in 2019. This report studies the global market for drug device combination products from the perspective of product types. The market is thus segmented into drug eluting stents, infusion pumps, bone graft implants, photodynamic therapy, wound care combination devices, inhalers, transdermal patches and others including intraocular implants and drug eluting beads. The market for all these product segments is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD billion. Each of the segments have been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD billion, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for drug eluting stents and infusion pumps. A chapter on recommendations for existing and new entrants is also provided in this report. Drug Device Combination Products Market: - Drug Eluting Stents - Infusion Pumps - Photosensitizers - Orthopedic Combination Products - Wound Care Combination Products - Inhalers - Transdermal Patches - Intraocular Implants and Drug Eluting Beads Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Drug Device Combination Products, by Type, Size and Forecast, 2011-2019 (USD Billion) Chapter 5 Global Drug Device Combination Products, by Geography, 2011 - 2019 (USD Million) Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles - Abbott Laboratories - Alcon, Inc. - Allergan, Inc. - Arrow International, Inc. - Bausch & Lomb, Inc. - Boston Scientific Corporation - C.R. Bard, Inc. - CareFusion Corporation - Covidien PLC - Ethicon, Inc. - Medline Industries, Inc. - Medtronic, Inc. - Mylan, Inc. - Pinnacle Biologics, Inc. - Stryker Corporation - Terumo Corporation - W. L. Gore & Associates, Inc. For more information visit http://www.researchandmarkets.com/research/wm...rug_device
Concise Analysis of the International Intravascular Ultrasound (IVUS) Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/mgsk4v/intravascular) has announced the addition of the "Concise Analysis of the International Intravascular Ultrasound (IVUS) Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period of 2009 through 2018. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Intravascular Ultrasound (IVUS) in US$ Thousand by the following Product Segments: - Intravascular Ultrasound (IVUS) Catheters - Intravascular Ultrasound (IVUS) Consoles Company profiles are primarily based on public domain information including company URLs. The report profiles 10 companies including many key and niche players such as: - Boston Scientific Corp. - InfraReDx, Inc. - Silicon Valley Medical Instruments, Inc. - Terumo Corp. - Volcano Corp. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends & Growth Drivers 3. Issues And Challenges 4. Competitive Landscape 5. Clinical Studies 6. Product Overview 7. Coronary Stents Market - A Brief Overview 8. Product Approvals/Introductions 9. Recent Industry Activity 10. Focus On Select Players 11. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 10 (including Divisions/Subsidiaries - 12) - The United States (7) - Japan (3) - Europe (2) - Germany (1) - Rest of Europe (1) For more information visit http://www.researchandmarkets.com/research/mg...ravascular
Reps Committee Commends CBN On Remmittance
All Africa Global Media - Wed Feb 26, 4:04AM CST
The House of Representatives Committee on Finance on Tuesday commended the Central Bank of Nigeria for its timely remittance to the Federation Account.
EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
Marketwire - Tue Feb 25, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 10:00 am Eastern Time at the Boston Marriott Copley Place in Boston, MA.
EURO RESSOURCES REPORTS EARNINGS FOR THE YEAR ENDED DECEMBER 31, 2013
GlobeNewswire - Fri Feb 21, 5:48PM CST
EURO Ressources S.A. ("EURO" or the "Company" (Paris: EUR) today announced its audited statutory financial results prepared in accordance with French Generally Accepted Accounting Principles ("GAAP" and its audited financial results prepared in accordance with International Financial Reporting Standards ("IFRS" for the year ended December 31, 2013. These audited financial results were approved by the Board of Directors on February 21, 2014. All financial amounts are expressed in Euros unless otherwise specified.
Global Central Venous Access Devices Market 2014-2018: Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc. and Teleflex Inc Among Top Vendors
M2 - Mon Feb 17, 9:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/4268p7/global_central) has announced the addition of the "Global Central Venous Access Devices Market 2014-2018" report to their offering. The analysts forecast the Global Central Venous Access Devices market to grow at a CAGR of 4.10 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing aging population. The Global Central Venous Access Devices market has also been witnessing the increased use of antimicrobial catheters. However, the high risk of vein thrombosis could pose a challenge to the growth of this market. Key vendors dominating this space are AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc., and Teleflex Inc. Other vendors mentioned in the report are Boston Scientific Corp., Covidien Plc., Edwards Lifesciences Corp., Medical Components Inc., Smiths Medical, Terumo Corp., and Vygon Corp. Commenting on the report, an analyst from the team said: Following the change of reimbursement policies (offered under Medicare and Medicaid) in the recent past, there has been an increase in the use of antimicrobial catheters. According to the changes, reimbursement would no longer be provided for treatment of vascular access-related infections acquired during a patient's hospitalization. The antimicrobial CVCs are inserted directly into the bloodstream through the large internal jugular, subclavian, and femoral veins, making them highly susceptible to infection. The complete CVC kits include maximum barrier drapes, manufactured catheter securement devices, and the antimicrobial agent (chlorhexidine) that is highly adopted by surgeons. The demand for dialysis catheters with intraluminal antimicrobial properties has also increased over the years. In addition, antimicrobial PICCs are extensively used to deliver chemotherapy and antibiotics as well as for drawing blood from immunocompromised patients. According to the report, one of the main drivers in this market is the increasing aging population that has led to an increase in demand for central venous access devices for delivering drugs, nutritional support, or aspiration of blood for sampling. For more information visit http://www.researchandmarkets.com/research/42...al_central About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BIOLASE Comments on $5 Million Private Placement With Oracle Investment Management, Inc.
Marketwire - Wed Feb 12, 11:16AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase, and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography and Galaxy CAD/CAM systems for dentistry, today commented on its recent $5 million private placement with Oracle Partners LP.
Concise Analysis of the International Anesthesia Devices Market
M2 - Fri Jan 31, 6:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/9x3jx2/anesthesia) has announced the addition of the "Concise Analysis of the International Anesthesia Devices Market" report to their offering. Anesthesia device product segments analyzed in this study include Delivery Machines, Disposables & Accessories, Monitors and Information Systems. The global market for Anesthesia Devices is estimated at US$7.4 billion in 2013 and forecast to be US$8.1 billion in 2014. Maintaining a CAGR of about 7.5% between 2010 and 2020, Anesthesia Devices market worldwide is further projected to reach US$11.8 billion by 2020. The report reviews, analyses and projects the anesthesia devices market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 13 independent countries across North America - The United States and Canada; Europe - Germany, the United Kingdom, France, Italy, Spain, Bulgaria, Czech Republic and Hungary; Asia-Pacific - Japan, China and India. The study includes 84 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in US$ by geographic region and product segment. This report profiles 33 key global players and 39 major players across North America - 17; Europe - 13; Asia-Pacific - 8 and Rest of World - 1. Key Topics Covered: Table Of Contents: Part A: Global Market Perspective 1. Introduction 2. Key Market Trends 3. Key Global Players 4. Key Business Trends 5. Global Market Overview Part B: Regional Market Perspective 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part C: Guide To The Industry 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part
Annexure 1. Research Methodology 2. The Questionnaire 3. Feedback Companies Mentioned: - Ambu - Baxter International - Becton, Dickinson and Company - Cardinal Health - Dr?gerwerk AG & Co - Esaote SpA - Fisher & Paykel Healthcare Limited - GE Healthcare - Getinge - Hospira - Intersurgical - Kimberly-Clark Health Care - Leventon - Maquet GmbH & Co - Nihon Kohden Corporation - Parker Healthcare - Siare Engineering International Group - Smiths Medical - Sonosite - Teleflex Incorporated - Terumo Corporation - Unomedical For more information visit http://www.researchandmarkets.com/research/9x3jx2/anesthesia
Neurovascular Interventions - EU Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nd4wcl/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - EU Analysis and Market Forecasts" report to their offering. The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices. The neurovascular interventions market in the 5EU is a vast and dynamic market that consists of innovative and emerging technologies. Neurointerventional devices can be used to treat a variety of cerebrovascular indications such as intracranial aneurysms, AVMs, and dural AVFs, atherosclerotic disease, and stroke. In this report, the neurointerventional market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. Scope - An overview of Neurovascular, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the EU Neurovascular market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Neurovascular. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Neurovascular sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/nd4wcl/medipoint
MediPoint Report: Neurovascular Interventions - APAC Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cn25dz/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - APAC Analysis and Market Forecasts" report to their offering. The APAC neurovascular interventions market is a vast and dynamic market that consists of innovative and emerging technologies. Neurointerventional devices can be used to treat a variety of cerebrovascular indications such as intracranial aneurysms, AVMs, and dural AVFs, atherosclerotic disease, and stroke. In this report, the neurointerventional market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 Market Outlooks 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/cn25dz/medipoint
MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zzfs96/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts" report to their offering. The neurovascular interventions market will be driven by the rising prevalence of disease, the growing aging population, and the potential cost savings. The adoption of innovative technologies such as flow diverters and stent retrievers in Brazil will depend on the cost of, and availability of reimbursement for these devices. Flow diverters and stent retrievers are currently not reimbursed by the Brazilian public healthcare system and are associated with high costs. Scope - An overview of Neurovascular Interventions, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized South America Neurovascular Interventions market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Neurovascular Interventions. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Neurovascular Interventions sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/zzfs96/medipoint
MediPoint: US Neurovascular Interventions Analysis and Market Forecasts 2014-2020
M2 - Wed May 07, 8:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b4sqvw/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - US Analysis and Market Forecasts" report to their offering. The neurovascular interventions market in the US to reach $702m by 2020, increasing slowly throughout the forecast period. The neurovascular interventions market will be driven by: the rising prevalence of cerebrovascular disease; the cost savings incurred by government agencies, such as Medicare, and private health insurance companies; and the adoption of innovative technologies such as flow diverters and stent retrievers. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 US Market Outlook 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/b4sqvw/medipoint
Global Infusion Pumps Market 2013-2019 with CareFusion, Hospira, Baxter International, Fresenius Kabi, & Terumo Dominating
M2 - Tue Apr 22, 5:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kbssn4/infusion_pumps) has announced the addition of the "Infusion Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Infusion pumps are used to deliver therapeutic drugs and fluids such as plasma, dextrose and saline solutions, into a patient's body at a precisely controlled rate. These devices are efficiently used for infusion through several routes of administration such as intravenous, epidural, arterial, subcutaneous, peritoneal, enteral and intrathecal. The global infusion pumps market has witnessed significant growth in the past due to factors such as worldwide increase in number of patients with chronic pain, diabetes and cancer. This report provides an in-depth, comprehensive analysis of the global infusion pumps market from the three perspectives namely types of products, different applications and the major geographies. According to the type of products, the market is further segmented into five sub-categories namely large volume, disposable, syringe, ambulatory, and implantable infusion pumps. The report analyzes the market for various applications namely; analgesia, chemotherapy, diabetes, clinical nutrition and others. In addition to this, the global infusion pumps market has also been classified by the pumping channel type, into single channel and multiple channel infusion pumps. A detailed market analysis and forecast for these segments has been provided in this study, in terms of market revenue (USD million) for the period 2011 to 2019. The report also provides the compounded annual growth rate (CAGR %) for each product type and for geographic region for the forecast period 2013 to 2019, while market size estimations have been made considering 2012 as the base year and 2011 as a historical year. The market overview section of the report demonstrates the market dynamics and trends such as the drivers, restraints and opportunities which influence the current nature and also affect the future status of this field. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global infusion pumps market. Scope Products - Large Volume Infusion Pumps - Disposable Infusion Pumps - Syringe Infusion Pumps - Ambulatory Infusion Pumps - Implantable Infusion Pumps Pumping Channel - Single Channel Infusion Pumps - Multiple Channel Infusion Pumps Application Areas - Analgesia - Chemotherapy - Diabetes - Clinical Nutrition Key Topics Covered: - Introduction - Executive Summary - Global Infusion Pumps Market Overview - Global Infusion Pumps Market, by Product Type, 2011 - 2019 (USD Million) - Global Infusion Pumps Market, by Channel Type, 2011 - 2019 (USD Million) - Global Infusion Pumps Market, by Application, 2011 - 2019 (USD Million) - Global Infusion Pumps Market, by Geography, 2011 - 2019 (USD Million) - Competitive Landscape - Recommendations - Company Profiles - Animas Corporation - B. Braun Melsungen AG - Baxter International Inc. - CareFusion Corporation - Fresenius Kabi AG - Hospira, Inc. - KD Scientific, Inc. - Medtronic, Inc. - Smiths Medical - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/kb...sion_pumps
Global Central Venous Access Devices Market Forecasts & Opportunities Report, 2018
M2 - Tue Apr 22, 2:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xdl79x/global_central) has announced the addition of the "Global Central Venous Access Devices Market Forecasts & Opportunities Report, 2018" report to their offering. One of the main drivers in this market is the increasing aging population that has led to an increase in demand for central venous access devices for delivering drugs, nutritional support, or aspiration of blood for sampling. Following the change of reimbursement policies (offered under Medicare and Medicaid) in the recent past, there has been an increase in the use of antimicrobial catheters. According to the changes, reimbursement would no longer be provided for treatment of vascular access-related infections acquired during a patient's hospitalization. The antimicrobial CVCs are inserted directly into the bloodstream through the large internal jugular, subclavian, and femoral veins, making them highly susceptible to infection. The complete CVC kits include maximum barrier drapes, manufactured catheter securement devices, and the antimicrobial agent (chlorhexidine) that is highly adopted by surgeons. The demand for dialysis catheters with intraluminal antimicrobial properties has also increased over the years. In addition, antimicrobial PICCs are extensively used to deliver chemotherapy and antibiotics as well as for drawing blood from immunocompromised patients. Further, the report states that one of the major challenges faced by the market is the high risk of vein thrombosis that can lead to a pulmonary embolism and may prove to be fatal. Key vendors dominating this space are: - AngioDynamics Inc. - B. Braun Melsungen AG - Becton, Dickinson and Co. - Cook Medical Inc - C.R Bard Inc - Teleflex Inc. Other vendors mentioned in the report are: - Boston Scientific Corp - Covidien Plc - Edwards Lifesciences Corp. - Medical Components Inc - Smiths Medical - Terumo Corp. - Vygon Corp. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/xd...al_central
Global Drug-eluting Stent Market 2014-2018 with Abbott Laboratories, Boston Scientific, Medtronic & Terumo Dominating
M2 - Thu Apr 17, 5:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c6b9zf/global) has announced the addition of the "Global Drug-eluting Stent Market 2014-2018 with Abbott Laboratories, Boston Scientific, Medtronic & Terumo Dominating" report to their offering. One of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD. Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries. Further, the report states that the biggest challenge the market is facing is the decline in the ASP of DESs. There has been a steady decline in the prices of DESs worldwide because of the increased competition and the high rate of adoption. The reduction in the ASP has a negative impact on the overall market revenue. Key vendors dominating this space are: - Abbott Laboratories - Boston Scientific Corp - Medtronic Inc. - Terumo Corp. Other vendors mentioned in the report are: - B. Braun Melsungen AG - Biosensors International Ltd - BIOTRONIK SE & Co. KG - Cook Medical Inc. - Lepu Medical Technology Co. Ltd - MicroPort Scientific Corp. - Sorin Group USA Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Types of Drugs - Geographical Segmentation - Key Leading Countries - Rate of Incidence and Prevalence - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/c6b9zf/global
Global Peripheral I.V. Catheter Market 2014-2018 with Braun, CR Bard, Smiths Medical, Teleflex, Terumo & Becton Dickension Dominating
M2 - Wed Apr 16, 5:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zzpzkc/global_peripheral) has announced the addition of the "Global Peripheral I.V. Catheter Market 2014-2018 with Braun, CR Bard, Smiths Medical, Teleflex, Terumo & Becton Dickension Dominating" report to their offering. The Global Peripheral I.V. Catheter market to grow at a CAGR of 8.08 percent over the period 2013-2018. The Global Peripheral I.V. Catheter market is driven by several factors, a major one being the increasing aging population. The elderly require peripheral I.V. catheters to deliver drugs and nutrition, and for taking blood samples. Also, WHO statistics state that nearly 2 billion people will be aged 60 years and above by 2050, which will also enhance the market's growth in the future. One of the emerging trends in the market is the adoption of power-injectable closed catheters for the injection of contrast media during CT imaging. CT imaging requires a contrast media to be used for enhanced visualization during diagnostic procedures. However, the catheter must be strong enough to withstand pressures that can be more than 300 psi. Hence, power-injectable closed catheters are used for CT imaging as they are made of polyurethane material, which is much stronger than silicone and can withstand high pressures with a minimal decrease in flexibility. For example, BD Nexiva closed I.V. catheter of BD helps inject contrast media for contrast-enhanced CT scans. Further, the report states that the high cost of integrated/closed catheters is proving to be a hindrance to the adoption of these catheters, particularly in developing countries. Closed catheters are offered at an average selling price of more than US$4, which makes their adoption quite difficult in developing countries. Key Vendors - B. Braun Melsungen AG - Becton, Dickenson and Co. - C.R. Bard Inc. - Smiths Medical - Tangent Medical Technologies - Teleflex Inc. - Terumo Corp. Other Prominent Vendors - Argon Medical Devices Inc. - Medical Components Inc. - Vascular Pathways Inc. - VIGMED AB - Vygon SA Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Global Vascular Access Catheter Market Segmentation - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/zz...peripheral
Global Infusion Pumps & Accessories (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump) Market 2014-2018
M2 - Fri Apr 11, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n6xwqb/infusion_pumps) has announced the addition of the "Infusion Pumps & Accessories Market by Product, Application & by End-user - Global Forecasts to 2018" report to their offering. The infusion pumps market is expected to grow at a moderate CAGR from 2013 to 2018 due to factors such as increasing chronic diseases, rising applications of infusion products in home care, and favorable reimbursement coverage for the use of infusion products. Despite of these growth factors, the increasing errors with use of infusion pumps and rising pressures to meet with stringent regulatory requirements may hamper the growth of this market to a certain extent. The global market is segmented on the basis of product types, applications, end users, and geographies. Based on the type of product, the market is further segmented into devices (pumps) and accessories/disposables. The accessories/disposables are further segmented into dedicated disposables and non-dedicated disposables. Depending on the application area, the market is classified into diabetes, chemotherapy/oncology, gastroenterology, hematology, analgesia/pain management, pediatrics/neonatology, and others. Based on end users, the market is categorized into hospitals, home care, and others. The overall market is further divided into four major geographies, namely North America, Europe, Asia-Pacific, and the Rest of the World (RoW). These regions are further analyzed at the country level. In 2013, the volumetric infusion pumps segment commanded the largest share of the global market and is expected to grow with moderate CAGR in next five years. The increasing applications and acceptance of insulin infusion pumps, patient controlled analgesia pumps, and implantable infusion pumps is expected to push the growth of these segments at a strong CAGR during the forecast period of 2013 to 2018. North America dominated the infusion pumps market in 2013, accounting for a share of around 40% to 45%. However, the developed geographies like North America and Europe are likely to grow at lower CAGRs than the Asia-Pacific and RoW markets. The growing economical condition, increasing healthcare expenditures, and rising adoption of newer technologies in the Asia-Pacific region will drive the market in this region. Scope Product - Volumetric - Syringe - Enteral - Insulin - Implantable - PCA Pump Application - Diabetes - Chemotherapy - Nutrition - Pain Management Key Topics Covered: - Introduction - Executive Summary - Premium Insight - Market Dynamics - Infusion Pumps & Accessories Market, By Product - Infusion Pumps And Accessories Market, By Application - Infusion Pumps And Accessories Market, By End User - Geographic Analysis - Competitive Landscape - Company Profiles - B. Braun Melsungen Ag - Baxter International Inc. - Carefusion Corporation - Fresenius Se & Co. Kgaa - ospira, Inc. - Johnson & Johnson - Medtronic, Inc. - Moog Inc. - Smiths Medical - Terumo Corporation Visit http://www.researchandmarkets.com/research/n6...sion_pumps
EnteroMedics Inc. Appoints Mark Bullivant as Vice President of Marketing
Marketwire - Wed Apr 09, 6:01AM CDT
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, is pleased to announced that Mark Bullivant has joined the organization as Vice President of Marketing. He will report to Greg S. Lea, Senior Vice President, Chief Financial Officer and Chief Operating Officer. Most recently, Mr. Bullivant was Vice President of Global Marketing and International Sales at Terumo Heart Inc., a subsidiary of Terumo Corporation where he was responsible for developing strategic sales and marketing plans with focus on expanding the business in US and International markets. Mark brings 20 years of product management experience in both the medical and surgical fields.
Neurovascular Interventions - Global Analysis and Market Forecasts 2014
M2 - Tue Apr 08, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/95ztzv/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts" report to their offering. Sales of Neurointerventional Devices by Region In this report, the neurovascular interventions market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. In 2013 in the 10MM, the neurovascular interventions market was approximately $1.37bn. We estimate the 2014 sales of neurointerventional devices for cerebrovascular applications to be $1.40bn across the 10 countries covered in this report, which are the US, France, Germany, Italy, Spain, the UK, Japan, China, India, and Brazil. Embolization, revascularization, and mechanical thrombectomy devices can be used for a wide range of cerebrovascular indications including intracranial aneurysms and arteriovenous malformations (AVMs), dural arteriovenous fistulas (DAVFs), atherosclerotic disease, and stroke. Endovascular therapy for neurovascular applications is rapidly expanding and provides effective results. The key drivers for this market during the forecast period are: - The rising prevalence of cerebrovascular disease and its associated risk factors in the major markets covered in this report. - The need for effective therapies that reduce the risk of hemorrhagic and stroke complications, and ensure long-term, reliable outcomes. - The improved outcomes with endovascular coiling for intracranial aneurysm treatment compared with surgical therapy. - The increased use of remodeling techniques such as stent-assisted and balloon-assisted coiling, and the adoption of flow diverters for the treatment of challenging/complex aneurysms (wide-neck, large, and giant aneurysms). - Improved recanalization rates with mechanical thrombectomy systems, where the need for chemical thrombolysis is eliminated, thereby reducing the risk of intracranial hemorrhage. - The cost savings for healthcare payers resulting from the reduced need for repeat procedures. - The increase in patients' disposable income and government insurance coverage in the emerging markets, such as China and India. - The approval and launch of the next-generation of innovative embolization, revascularization, and mechanical thrombectomy devices in the US and Japan. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 Market Outlooks 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/95ztzv/medipoint
Arterial Remodeling Technologies ('ART'
signs structured buyout agreement with Terumo, validating ART's next-gen bioresorbable scaffold Business Wire - Thu Mar 27, 8:44AM CDT
Privately held Arterial Remodeling Technologies ('ART'
announced today that it has signed a structured buyout agreement with Terumo Corporation. Under the agreement, ART and Terumo Corporation will collaborate in the development of a drug eluting bioresorbable scaffold or stent, intended for use in the treatment of coronary artery disease. ART Security Holders will retain full ownership of the ART bioresorbable scaffold technology for all other indications. Terumo Corporation will make staged R&D investments in ART and ART has granted an exclusive option to Terumo Corporation to purchase ART at any time prior to the initiation of clinical trials. Drug Device Combination Products Market Report 2013 - 2019: Forecasts & Trends for the $US100 Billion Market
M2 - Tue Mar 18, 11:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wmt3kk/drug_device) has announced the addition of the "Drug Device Combination Products Market Report 2013 - 2019: Forecasts & Trends for the $US100 Billion Market" report to their offering. The global drug device combination products market was valued at USD 66 billion in 2012 and is expected to grow at a CAGR of 7.9% from 2013 to 2019, to reach an estimated value of USD 115 billion in 2019. This report studies the global market for drug device combination products from the perspective of product types. The market is thus segmented into drug eluting stents, infusion pumps, bone graft implants, photodynamic therapy, wound care combination devices, inhalers, transdermal patches and others including intraocular implants and drug eluting beads. The market for all these product segments is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD billion. Each of the segments have been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD billion, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for drug eluting stents and infusion pumps. A chapter on recommendations for existing and new entrants is also provided in this report. Drug Device Combination Products Market: - Drug Eluting Stents - Infusion Pumps - Photosensitizers - Orthopedic Combination Products - Wound Care Combination Products - Inhalers - Transdermal Patches - Intraocular Implants and Drug Eluting Beads Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Drug Device Combination Products, by Type, Size and Forecast, 2011-2019 (USD Billion) Chapter 5 Global Drug Device Combination Products, by Geography, 2011 - 2019 (USD Million) Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles - Abbott Laboratories - Alcon, Inc. - Allergan, Inc. - Arrow International, Inc. - Bausch & Lomb, Inc. - Boston Scientific Corporation - C.R. Bard, Inc. - CareFusion Corporation - Covidien PLC - Ethicon, Inc. - Medline Industries, Inc. - Medtronic, Inc. - Mylan, Inc. - Pinnacle Biologics, Inc. - Stryker Corporation - Terumo Corporation - W. L. Gore & Associates, Inc. For more information visit http://www.researchandmarkets.com/research/wm...rug_device
Concise Analysis of the International Intravascular Ultrasound (IVUS) Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/mgsk4v/intravascular) has announced the addition of the "Concise Analysis of the International Intravascular Ultrasound (IVUS) Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period of 2009 through 2018. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Intravascular Ultrasound (IVUS) in US$ Thousand by the following Product Segments: - Intravascular Ultrasound (IVUS) Catheters - Intravascular Ultrasound (IVUS) Consoles Company profiles are primarily based on public domain information including company URLs. The report profiles 10 companies including many key and niche players such as: - Boston Scientific Corp. - InfraReDx, Inc. - Silicon Valley Medical Instruments, Inc. - Terumo Corp. - Volcano Corp. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends & Growth Drivers 3. Issues And Challenges 4. Competitive Landscape 5. Clinical Studies 6. Product Overview 7. Coronary Stents Market - A Brief Overview 8. Product Approvals/Introductions 9. Recent Industry Activity 10. Focus On Select Players 11. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 10 (including Divisions/Subsidiaries - 12) - The United States (7) - Japan (3) - Europe (2) - Germany (1) - Rest of Europe (1) For more information visit http://www.researchandmarkets.com/research/mg...ravascular
Reps Committee Commends CBN On Remmittance
All Africa Global Media - Wed Feb 26, 4:04AM CST
The House of Representatives Committee on Finance on Tuesday commended the Central Bank of Nigeria for its timely remittance to the Federation Account.
EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
Marketwire - Tue Feb 25, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 10:00 am Eastern Time at the Boston Marriott Copley Place in Boston, MA.
EURO RESSOURCES REPORTS EARNINGS FOR THE YEAR ENDED DECEMBER 31, 2013
GlobeNewswire - Fri Feb 21, 5:48PM CST
EURO Ressources S.A. ("EURO" or the "Company"
(Paris: EUR) today announced its audited statutory financial results prepared in accordance with French Generally Accepted Accounting Principles ("GAAP" and its audited financial results prepared in accordance with International Financial Reporting Standards ("IFRS" for the year ended December 31, 2013. These audited financial results were approved by the Board of Directors on February 21, 2014. All financial amounts are expressed in Euros unless otherwise specified. Global Central Venous Access Devices Market 2014-2018: Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc. and Teleflex Inc Among Top Vendors
M2 - Mon Feb 17, 9:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/4268p7/global_central) has announced the addition of the "Global Central Venous Access Devices Market 2014-2018" report to their offering. The analysts forecast the Global Central Venous Access Devices market to grow at a CAGR of 4.10 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing aging population. The Global Central Venous Access Devices market has also been witnessing the increased use of antimicrobial catheters. However, the high risk of vein thrombosis could pose a challenge to the growth of this market. Key vendors dominating this space are AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc., and Teleflex Inc. Other vendors mentioned in the report are Boston Scientific Corp., Covidien Plc., Edwards Lifesciences Corp., Medical Components Inc., Smiths Medical, Terumo Corp., and Vygon Corp. Commenting on the report, an analyst from the team said: Following the change of reimbursement policies (offered under Medicare and Medicaid) in the recent past, there has been an increase in the use of antimicrobial catheters. According to the changes, reimbursement would no longer be provided for treatment of vascular access-related infections acquired during a patient's hospitalization. The antimicrobial CVCs are inserted directly into the bloodstream through the large internal jugular, subclavian, and femoral veins, making them highly susceptible to infection. The complete CVC kits include maximum barrier drapes, manufactured catheter securement devices, and the antimicrobial agent (chlorhexidine) that is highly adopted by surgeons. The demand for dialysis catheters with intraluminal antimicrobial properties has also increased over the years. In addition, antimicrobial PICCs are extensively used to deliver chemotherapy and antibiotics as well as for drawing blood from immunocompromised patients. According to the report, one of the main drivers in this market is the increasing aging population that has led to an increase in demand for central venous access devices for delivering drugs, nutritional support, or aspiration of blood for sampling. For more information visit http://www.researchandmarkets.com/research/42...al_central About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BIOLASE Comments on $5 Million Private Placement With Oracle Investment Management, Inc.
Marketwire - Wed Feb 12, 11:16AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase, and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography and Galaxy CAD/CAM systems for dentistry, today commented on its recent $5 million private placement with Oracle Partners LP.
Concise Analysis of the International Anesthesia Devices Market
M2 - Fri Jan 31, 6:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/9x3jx2/anesthesia) has announced the addition of the "Concise Analysis of the International Anesthesia Devices Market" report to their offering. Anesthesia device product segments analyzed in this study include Delivery Machines, Disposables & Accessories, Monitors and Information Systems. The global market for Anesthesia Devices is estimated at US$7.4 billion in 2013 and forecast to be US$8.1 billion in 2014. Maintaining a CAGR of about 7.5% between 2010 and 2020, Anesthesia Devices market worldwide is further projected to reach US$11.8 billion by 2020. The report reviews, analyses and projects the anesthesia devices market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 13 independent countries across North America - The United States and Canada; Europe - Germany, the United Kingdom, France, Italy, Spain, Bulgaria, Czech Republic and Hungary; Asia-Pacific - Japan, China and India. The study includes 84 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in US$ by geographic region and product segment. This report profiles 33 key global players and 39 major players across North America - 17; Europe - 13; Asia-Pacific - 8 and Rest of World - 1. Key Topics Covered: Table Of Contents: Part A: Global Market Perspective 1. Introduction 2. Key Market Trends 3. Key Global Players 4. Key Business Trends 5. Global Market Overview Part B: Regional Market Perspective 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part C: Guide To The Industry 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part
Annexure 1. Research Methodology 2. The Questionnaire 3. Feedback Companies Mentioned: - Ambu - Baxter International - Becton, Dickinson and Company - Cardinal Health - Dr?gerwerk AG & Co - Esaote SpA - Fisher & Paykel Healthcare Limited - GE Healthcare - Getinge - Hospira - Intersurgical - Kimberly-Clark Health Care - Leventon - Maquet GmbH & Co - Nihon Kohden Corporation - Parker Healthcare - Siare Engineering International Group - Smiths Medical - Sonosite - Teleflex Incorporated - Terumo Corporation - Unomedical For more information visit http://www.researchandmarkets.com/research/9x3jx2/anesthesia 
